ADAP
Price
$0.61
Change
+$0.01 (+1.67%)
Updated
Dec 18, 04:59 PM (EDT)
71 days until earnings call
INZY
Price
$2.77
Change
-$0.17 (-5.78%)
Updated
Dec 18, 04:59 PM (EDT)
92 days until earnings call
Ad is loading...

ADAP vs INZY

Header iconADAP vs INZY Comparison
Open Charts ADAP vs INZYBanner chart's image
Adaptimmune Therapeutics
Price$0.61
Change+$0.01 (+1.67%)
Volume$49.34K
CapitalizationN/A
Inozyme Pharma
Price$2.77
Change-$0.17 (-5.78%)
Volume$5.02K
CapitalizationN/A
ADAP vs INZY Comparison Chart
Loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAP vs. INZY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Hold and INZY is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ADAP: $0.60 vs. INZY: $2.94)
Brand notoriety: ADAP and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAP: 129% vs. INZY: 95%
Market capitalization -- ADAP: $153.38M vs. INZY: $188.87M
ADAP [@Biotechnology] is valued at $153.38M. INZY’s [@Biotechnology] market capitalization is $188.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • ADAP’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, ADAP is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • ADAP’s TA Score: 4 bullish, 4 bearish.
  • INZY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADAP and INZY are a good buy in the short-term.

Price Growth

ADAP (@Biotechnology) experienced а -3.77% price change this week, while INZY (@Biotechnology) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

ADAP is expected to report earnings on Feb 27, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($189M) has a higher market cap than ADAP($153M). ADAP YTD gains are higher at: -24.414 vs. INZY (-30.986).
ADAPINZYADAP / INZY
Capitalization153M189M81%
EBITDAN/AN/A-
Gain YTD-24.414-30.98679%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ADAP: Fundamental Ratings
ADAP
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAPINZY
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ADAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with CYTK. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
+1.35%
CYTK - ADAP
36%
Loosely correlated
-2.53%
INZY - ADAP
35%
Loosely correlated
-2.65%
NUVB - ADAP
34%
Loosely correlated
+4.46%
KYMR - ADAP
34%
Loosely correlated
-1.76%
ORIC - ADAP
33%
Loosely correlated
+0.12%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-2.65%
BEAM - INZY
57%
Loosely correlated
-1.21%
NAUT - INZY
51%
Loosely correlated
-1.00%
DNLI - INZY
50%
Loosely correlated
-0.30%
ABOS - INZY
49%
Loosely correlated
-0.51%
FULC - INZY
49%
Loosely correlated
+2.71%
More